SUMATRIPTAN SUN 3 mg/0.5 ml, solution for injection in a pre-filled syringe (route SC) 2 syringes of 0.5 ml
Active ingredients: Sumatriptan succinate, Sumatriptan
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 syringes of 0.5 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SUMATRIPTAN SUN 3 mg/0,5 ml, solution injectable en seringue préremplie (voie SC)
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 seringue(s) préremplie(s) en verre de 0,5 ml avec injecteur(s) automatique(s)
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Aug 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64869780CIP73020350CIP133400930203507Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUCCINATE DE SUMATRIPTANsolution | — | SA |
| SUMATRIPTANsolution | 3 mg · une seringue préremplie de 0,5 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.